A new strategy for immunotherapy of microsatellite‐stable (MSS)‐type advanced colorectal cancer: Multi‐pathway combination therapy with PD‐1/PD‐L1 inhibitors
Authors:
- 22 March 2024
- journal article
- review article
- Published by Wiley in Immunology
- Vol. 173 (2) , 209-226
Abstract
Colorectal cancer (CRC) is a frequent gastrointestinal malignancy with high rates of morbidity and mortality; 85% of these tumours are proficient mismatch repair (pMMR)‐microsatellite instability‐low (MSI‐L)/microsatellite stable (MSS) CRC known as ‘cold’ tumours that are resistant to immunosuppressive drugs. Monotherapy with programmed death 1 (PD‐1)/programmed death ligand 1 (PD‐L1) inhibitors is ineffective for treating MSS CRC, making immunotherapy for MSS CRC a bottleneck. Recent studies have found that the multi‐pathway regimens combined with PD‐1/PD‐L1 inhibitors can enhance the efficacy of anti‐PD‐1/PD‐L1 in MSS CRC by increasing the number of CD8+ T cells, upregulating PD‐L1 expression and improving the tumour microenvironment. This paper reviews the research progress of PD‐1/PD‐L1 inhibitors in combination with cytotoxic T‐lymphocyte–associated antigen 4 (CTLA‐4) inhibitors, oncolytic virus, intestinal flora, antiangiogenic agents, chemotherapy, radiotherapy and epigenetic drugs for the treatment of pMMR‐MSI‐L/MSS CRC.Keywords
This publication has 101 references indexed in Scilit:
- Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironmentCell, 2021
- The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph NodesCancer Cell, 2020
- Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal CancerJAMA Oncology, 2020
- Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non–Small Cell Lung CancerJAMA Oncology, 2020
- Is it true that gut microbiota is considered as panacea in cancer therapy?Journal of Cellular Physiology, 2019
- Back to the Colorectal Cancer Consensus Molecular Subtype FutureCurrent Gastroenterology Reports, 2019
- Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 ImmunotherapyCell, 2017
- Oncolytic Viruses in Cancer TreatmentJAMA Oncology, 2017
- Chemoimmunotherapy by combining oxaliplatin with immune checkpoint blockades reduced tumor burden in colorectal cancer animal modelBiochemical and Biophysical Research Communications, 2017
- Genomic Correlates of Immune-Cell Infiltrates in Colorectal CarcinomaCell Reports, 2016